Abbott Laboratories (ABT) Down on Buying St. Jude

Abbott Laboratories ABT shares fell 6.5% to $40.98, after the company entered into an agreement to acquire St. Jude for $25 billion. Share volume was 2.6 million, besting an all-day average of 1.7 million
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!